Healthcare providers assess symptoms and medical history to determine the need for further testing
In clinical observations, constipation tends to improve as the patient continues treatment and the digestive system adapts to the slowed motility caused by the medication
KLOW is administered as subcutaneous injections
Topiramate Topiramate acts as a modulator on sodium ion channels, gamma-aminobutyric acid (GABA) receptors, and AMPA/kainate receptors, which affects food-seeking behavior [7]
A monotherapy-first approach would have been just as defensible, arguably more conventional, and because we used both drugs at once, we cannot say how much each one contributed to the recovery
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study